The Effect of Upper Limb Loading During Partial Body Weight Support Treadmill Training in Children With Cerebral Palsy
Launched by ALYA ABDELGHAFOUR ALKHAJEH · Jun 30, 2022
Trial Information
Current as of June 19, 2025
Unknown status
Keywords
ClinConnect Summary
Cerebral Palsy (CP) is a non-progressive neurodevelopmental disorder which affects the child's motor and sensory system, and consequently posture and walking. The underlying etiology is considered multifactorial, and no specific etiological factor has been blamed. While it may be seen in the prenatal, neonatal, and postnatal period, prenatal factors account for 70 to 80 % of all cases. Although the incidence of cerebral palsy widely varies worldwide, it has been often estimated as 1.5 to 2.5/1000. While the prevalence in young people is as high as 74%. One of the characteristics of CP is ga...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of CP confirmed by the neurologist
- • Age between 4 to 8 years
- • Both genders
- • The level of gross motor function is between level I and II according to Gross Motor Function Classification System (GMFCS)
- • The degree of spasticity according to Modified Ashworth Scale range between grade 1 and grade 2
- • Children should be cognitively competent with IQ level not less than 60% and able to understand and follow instructions, as well as, in general they are cooperative
- • Only Arabic and English speakers will be recruited in the study
- Exclusion Criteria:
- • Had any orthopedic surgery or spasticity altering procedure in the previous 12 months
- • Children with visual, auditory, vestibular or perceptual deficits.
About Alya Abdelghafour Alkhajeh
Alya Abdelghafour Alkhajeh is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a background in healthcare and extensive experience in clinical trial management, Alya's focus is on ensuring the highest standards of compliance, safety, and efficacy throughout the research process. Passionate about fostering innovation, she collaborates with multidisciplinary teams to facilitate the development of groundbreaking therapies. Her leadership and strategic vision contribute to the successful execution of trials that address critical health challenges and enhance the understanding of therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sharjah, , United Arab Emirates
Patients applied
Trial Officials
Fatma Hegazy
Principal Investigator
UOS
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials